The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus : a systematic review and meta-analysis

2014
journal article
article
dc.affiliationWydział Nauk o Zdrowiu : Instytut Zdrowia Publicznegopl
dc.cm.date2020-01-07
dc.cm.id66060
dc.contributor.authorKawalec, Paweł - 130055 pl
dc.contributor.authorMikrut, Alicjapl
dc.contributor.authorŁopuch, Sylwiapl
dc.date.accessioned2020-01-17T08:43:44Z
dc.date.available2020-01-17T08:43:44Z
dc.date.issued2014pl
dc.description.number4pl
dc.description.physical269-283pl
dc.description.points30pl
dc.description.volume30pl
dc.identifier.doi10.1002/dmrr.2494pl
dc.identifier.eissn1520-7560pl
dc.identifier.issn1520-7552pl
dc.identifier.projectROD UJ / Opl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/133580
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licencebez licencji
dc.subtypeArticlepl
dc.titleThe safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus : a systematic review and meta-analysispl
dc.title.journalDiabetes/Metabolism Research and Reviewspl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego
dc.cm.date
2020-01-07
dc.cm.id
66060
dc.contributor.authorpl
Kawalec, Paweł - 130055
dc.contributor.authorpl
Mikrut, Alicja
dc.contributor.authorpl
Łopuch, Sylwia
dc.date.accessioned
2020-01-17T08:43:44Z
dc.date.available
2020-01-17T08:43:44Z
dc.date.issuedpl
2014
dc.description.numberpl
4
dc.description.physicalpl
269-283
dc.description.pointspl
30
dc.description.volumepl
30
dc.identifier.doipl
10.1002/dmrr.2494
dc.identifier.eissnpl
1520-7560
dc.identifier.issnpl
1520-7552
dc.identifier.projectpl
ROD UJ / O
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/133580
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
bez licencji
dc.subtypepl
Article
dc.titlepl
The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus : a systematic review and meta-analysis
dc.title.journalpl
Diabetes/Metabolism Research and Reviews
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
1
Views per month

No access

No Thumbnail Available